Page last updated: 2024-08-23

dihydro-beta-erythroidine and Drug Withdrawal Symptoms

dihydro-beta-erythroidine has been researched along with Drug Withdrawal Symptoms in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's9 (64.29)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, JA; Gould, TJ1
Markou, A; Semenova, S1
Dani, JA; Dong, Y; Doyon, WM; Zhang, L1
Imad Damaj, M; Jackson, KJ1
Markou, A; Skjei, KL1
Bruijnzeel, AW; Markou, A1
Kenny, PJ; Markou, A1
Barik, J; Wonnacott, S1
Jonkman, S; Markou, A1
Gould, TJ; Kenney, JW; Portugal, GS1
Geyer, MA; Jonkman, S; Markou, A; Risbrough, VB1
Markou, A; Semenova, S; Stoker, AK1
Epping-Jordan, MP; Koob, GF; Markou, A; Watkins, SS1
Lake, JR; Malin, DH; Rajan, N; Schweinle, WE; Shenoi, M; Upchurch, TP1

Other Studies

14 other study(ies) available for dihydro-beta-erythroidine and Drug Withdrawal Symptoms

ArticleYear
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:8

    Topics: Animals; Cerebral Cortex; Conditioning, Operant; Dihydro-beta-Erythroidine; Fear; Hippocampus; Learning Disabilities; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microinjections; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Thalamus

2009
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:10

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Brain; Dihydro-beta-Erythroidine; Electrodes, Implanted; Fluorobenzenes; Ganglionic Stimulants; Idazoxan; Male; Nicotine; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Serotonin Antagonists; Substance Withdrawal Syndrome

2010
Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens.
    Biological psychiatry, 2012, Feb-01, Volume: 71, Issue:3

    Topics: Animals; Dihydro-beta-Erythroidine; Dopamine; Drug Administration Schedule; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Self Administration; Substance Withdrawal Syndrome; Time Factors

2012
Beta2-containing nicotinic acetylcholine receptors mediate calcium/calmodulin-dependent protein kinase-II and synapsin I protein levels in the nucleus accumbens after nicotine withdrawal in mice.
    European journal of pharmacology, 2013, Feb-15, Volume: 701, Issue:1-3

    Topics: Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dihydro-beta-Erythroidine; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Phosphoproteins; Phosphorylation; Receptors, Nicotinic; Signal Transduction; Substance Withdrawal Syndrome; Synapsins; Time Factors; Tobacco Use Disorder

2013
Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
    Psychopharmacology, 2003, Volume: 168, Issue:3

    Topics: Animals; Central Nervous System Stimulants; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Infusion Pumps, Implantable; Male; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Self Stimulation; Sensory Thresholds; Substance Withdrawal Syndrome

2003
Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats.
    Neuropharmacology, 2004, Volume: 47, Issue:4

    Topics: Adaptation, Physiological; Animals; Cholinergic Fibers; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Male; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Synaptic Transmission; Ventral Tegmental Area

2004
Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:6

    Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Dihydro-beta-Erythroidine; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Withdrawal Syndrome; Time Factors

2006
Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
    Molecular pharmacology, 2006, Volume: 69, Issue:2

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bacterial Toxins; Biological Transport; Conotoxins; Cyanobacteria Toxins; Dihydro-beta-Erythroidine; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Male; Marine Toxins; Microcystins; Neurons; Nicotine; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tetrodotoxin; Tropanes

2006
Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Neuroscience letters, 2006, May-29, Volume: 400, Issue:1-2

    Topics: Amygdala; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Dihydro-beta-Erythroidine; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Nicotine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Nicotinic; Septal Nuclei; Substance Withdrawal Syndrome; Tobacco Use Disorder

2006
Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning.
    Neurobiology of learning and memory, 2008, Volume: 89, Issue:2

    Topics: Acoustic Stimulation; Animals; Conditioning, Classical; Cues; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Environment; Fear; Female; Infusion Pumps, Implantable; Injections, Subcutaneous; Learning; Male; Mice; Mice, Inbred C57BL; Nicotine; Psychomotor Performance; Receptors, Nicotinic; Substance Withdrawal Syndrome

2008
Spontaneous nicotine withdrawal potentiates the effects of stress in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:9

    Topics: Acoustic Stimulation; Analysis of Variance; Animals; Behavior, Animal; Dihydro-beta-Erythroidine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Reflex, Startle; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors

2008
Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.
    Neuropharmacology, 2008, Volume: 54, Issue:8

    Topics: Acoustic Stimulation; Animals; Dihydro-beta-Erythroidine; Drug Implants; Emotions; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Reflex, Startle; Self Stimulation; Substance Withdrawal Syndrome; Tobacco Use Disorder

2008
Dramatic decreases in brain reward function during nicotine withdrawal.
    Nature, 1998, May-07, Volume: 393, Issue:6680

    Topics: Animals; Brain; Dihydro-beta-Erythroidine; Disease Models, Animal; Infusion Pumps, Implantable; Male; Motivation; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Self Stimulation; Sensory Thresholds; Substance Withdrawal Syndrome

1998
Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:3

    Topics: Animals; Cholinergic Agents; Dihydro-beta-Erythroidine; Injections, Intraventricular; Male; Muscarinic Antagonists; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Scopolamine; Substance Withdrawal Syndrome; Substance-Related Disorders

1998